Which has the lower trailing P/E, AZN or NVS?

NVS has the lower trailing P/E: AZN trades at 23.55 and NVS at 21.25. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or NVS?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus NVS at 1.53%.

Does AZN or NVS pay a bigger dividend?

AZN yields 2.05% and NVS yields 3.38% based on trailing dividends and the latest price.

Is AZN or NVS more profitable?

NVS runs the higher net margin — AZN at 17.02% versus NVS at 22.93%.

How have AZN and NVS total returns compared?

Over the past 10 years, AZN delivered 12.28% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Novartis AG (NVS)

A side-by-side comparison of AstraZeneca PLC and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$243.21B

$156.82HealthcareDelayed quote: Oct 2, 2026, 3:50 PM EDT

NVS

Novartis AG

$267.83B

$140.91HealthcareDelayed quote: Oct 2, 2026, 3:50 PM EDT

Total return — AZN vs NVS

growth of $100 · dividends reinvested · last 10y

AZN +236.6% (+12.9%/yr)NVS +219.0% (+12.3%/yr)AZN compounded faster over this window

AZN NVS

AZN vs NVS: by the numbers

•NVS is the larger company ($267.83B vs $243.21B market cap).
•NVS trades at the lower trailing earnings multiple (21.25 vs 23.55 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 17.02% net margin).
•AZN grew revenue faster over the past five years (15.76% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 2.05%).

Metrics side by side

Valuation

Metric	AZN	NVS
P/E ratio	23.55	21.25
Forward P/E	15.28	16.01
PEG ratio	1.08	1.38
P/S ratio	3.96	4.81
P/B ratio	4.84	6.45
EV / EBITDA	13.31	13.84
FCF yield	3.59%	5.91%

Profitability

Metric	AZN	NVS
Gross margin	81.88%	74.44%
Operating margin	22.77%	30.54%
Net margin	17.02%	22.93%
ROE	20.79%	30.71%
ROIC	12.83%	13.93%

Dividends

Metric	AZN	NVS
Dividend yield	2.05%	3.38%
Payout ratio	48.50%	71.50%

Growth (annualized)

Metric	AZN	NVS
Revenue CAGR (5Y)	15.76%	1.53%
EPS CAGR (5Y)	22.02%	15.42%
FCF CAGR (5Y)	14.53%	8.92%
Total return CAGR (5Y)	8.29%	16.96%

Frequently asked

Which has the lower trailing P/E, AZN or NVS?: NVS has the lower trailing P/E: AZN trades at 23.55 and NVS at 21.25. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or NVS?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus NVS at 1.53%.
Does AZN or NVS pay a bigger dividend?: AZN yields 2.05% and NVS yields 3.38% based on trailing dividends and the latest price.
Is AZN or NVS more profitable?: NVS runs the higher net margin — AZN at 17.02% versus NVS at 22.93%.
How have AZN and NVS total returns compared?: Over the past 10 years, AZN delivered 12.28% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Novartis AG P/E ratio AstraZeneca dividend yield Novartis AG dividend yield AstraZeneca ROE Novartis AG ROE AstraZeneca operating margin Novartis AG operating margin AstraZeneca revenue growth Novartis AG revenue growth AstraZeneca free cash flow Novartis AG free cash flow

AstraZeneca & Novartis AG appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.